Illumina, Inc. (ILMN) vs Mettler-Toledo International, Inc. (MTD)

Illumina, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $40.5B against $32.8B — 1.2× the size. Mettler-Toledo International, Inc. trades at the lower P/E: 36.4× against 48.4×. Mettler-Toledo International, Inc. grew revenue faster over the last twelve months: 6.91% against 4.88%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 18.4%) and the higher return on invested capital (35.4% vs 17.5%). Across the 22 metrics below, Mettler-Toledo International, Inc. leads on 14 and Illumina, Inc. on 8.

Valuation

Metric ILMN MTD Diagnostics & Research median
P/E 48.43 36.42 35.56
P/S 8.81 7.90 4.37
P/B 13.94 2,545.64 3.06
Price to free cash flow 43.19 37.78 35.76
EV/EBITDA 34.96 26.59 24.35
EV/Sales 8.99 8.40 5.51
Earnings yield 2.06% 2.75% (1.89%)
Free cash flow yield 2.32% 2.65% (0.15%)

Profitability

Metric ILMN MTD Diagnostics & Research median
Gross margin 66.39% 60.26% 50.89%
Operating margin 19.65% 28.41% (8.57%)
Net margin 18.36% 21.91% (6.37%)
Free cash flow margin 20.72% 20.90% 0.00%
Return on equity 32.38% (736.36%) (2.92%)
Return on assets 12.95% 25.61% (6.71%)
Return on invested capital 17.46% 35.40% 0.00%

Growth

Metric ILMN MTD Diagnostics & Research median
Revenue growth (TTM) 4.88% 6.91% 7.69%
EPS growth (last fiscal year) 170.87% 3.88% 25.92%
Revenue growth, 5-year CAGR 6.04% 5.47% 7.40%
Net income growth, 5-year CAGR 5.32% 7.60% 0.00%

Health

Metric ILMN MTD Diagnostics & Research median
Debt to equity 0.53 164.70 0.11
Current ratio 1.80 1.12 2.02
Net debt to EBITDA (0.13) 1.68 0.70

Dividend

Metric ILMN MTD Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ILMN MTD Diagnostics & Research median
Market cap 40.46b 32.84b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack